B-Cell Chronic Lymphocytic Leukemia
Showing 26 - 50 of 65
B-cell Chronic Lymphocytic Leukemia Trial in Austria (Fludarabine phosphate, Alemtuzumab)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Fludarabine phosphate
- Alemtuzumab
-
Feldkirch, Austria
- +7 more
Dec 6, 2017
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,
Completed
- Acute Lymphoblastic Leukemia
- +4 more
- ABT-348
- ABT-348 and azacitidine
-
Scottsdale, Arizona
- +2 more
Nov 16, 2017
B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
-
Columbus, OhioOhio State University Medical Center
Jun 2, 2017
B-Cell Chronic Lymphocytic Leukemia Trial in Canada, Russian Federation, Spain (Ibrutinib, Erythromycin, Voriconazole)
Completed
- B-Cell Chronic Lymphocytic Leukemia
- Ibrutinib
- +2 more
-
N/a N/a, Canada
- +5 more
Jun 23, 2017
B-cell Chronic Lymphocytic Leukemia Trial in Brazil (PCI-32765 (Ibrutinib))
Approved for marketing
- B-cell Chronic Lymphocytic Leukemia
- PCI-32765 (Ibrutinib)
-
Barretos, Brazil
- +6 more
Mar 17, 2017
B-Cell Chronic Lymphocytic Leukemia Trial in United States (Fludarabine, Cyclophosphamide, Rituximab)
Completed
- B-Cell Chronic Lymphocytic Leukemia
- Fludarabine
- +3 more
-
Ocoee, Florida
- +10 more
Sep 15, 2016
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
-
Columbus, OhioOhio State University Medical Center
Aug 31, 2016
B-cell Chronic Lymphocytic Leukemia Trial in Cologne (FCCam)
Completed
- B-cell Chronic Lymphocytic Leukemia
-
Cologne, NRW, GermanyUniversity of Cologne
Sep 30, 2016
B-Cell Chronic Lymphocytic Leukemia Trial in New Hyde Park (Hydroxychloroquine)
Terminated
- B-Cell Chronic Lymphocytic Leukemia
-
New Hyde Park, New YorkLong Island Jewish Medical Center CLL Research and Treatment Cen
Aug 18, 2016
B-cell Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in Buffalo (drug,
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- lenalidomide
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 26, 2016
B-Cell Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in Singapore (T-cell therapy + Rituximab + IL-2)
Unknown status
- B-Cell Chronic Lymphocytic Leukemia
- Non-Hodgkin's Lymphoma
- T-cell therapy + Rituximab + IL-2
-
Singapore, SingaporeNational University Hospital
Jun 21, 2016
B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cancer, Prolymphocytic Leukemia Trial in Columbus (carfilzomib,
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- carfilzomib
- +4 more
-
Columbus, OhioOhio State University Medical Center
May 6, 2016
B-cell Chronic Lymphocytic Leukemia Trial in Houston (B-CLL Vaccine, Lenalidomide)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- B-CLL Vaccine
- Lenalidomide
-
Houston, TexasHouston Methodist Hospital
Feb 5, 2016
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- alvespimycin hydrochloride
- +3 more
-
Columbus, OhioOhio State University Medical Center
Nov 3, 2015
Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial
Unknown status
- Hematopoietic/Lymphoid Cancer
- +22 more
- anti-CD20-CAR vector-transduced autologous T cells
- genetically engineered lymphocyte therapy
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
Sep 27, 2015
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
-
Columbus, OhioThe Ohio State University
May 28, 2015
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial (drug, biological, other, genetic)
Withdrawn
- B-cell Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- fludarabine phosphate
- +6 more
- (no location specified)
Mar 4, 2015
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (PCI-32765)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Boston, Massachusetts
- +5 more
Jul 17, 2014
B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- alemtuzumab
- +2 more
-
Chicago, Illinois
- +1 more
May 6, 2014
B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- sunitinib malate
- +2 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Apr 28, 2014
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (bevacizumab)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- bevacizumab
-
Rochester, MinnesotaMayo Clinic
Apr 21, 2014
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (PCI-32765)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Stanford, California
- +9 more
Feb 13, 2014
B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (FluCAM [Fludara + Campath], fludarabine phosphate)
Completed
- B-Cell Chronic Lymphocytic Leukemia
- FluCAM [Fludara + Campath]
- fludarabine phosphate
-
Fort Myers, Florida
- +47 more
Feb 10, 2014
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (thalidomide, laboratory
Completed
- B-cell Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- thalidomide
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Oct 7, 2013